New Japan Science Inc.
Basic information
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Satsuma | ||||||||
|
Fureai Support Co., Ltd.
|
||||||||
| メディポリス国際陽子線治療センター | ||||||||
|
New Japan Science PPD Co., Ltd.
|
||||||||
|
Shin Nihon General Construction Co., Ltd.
|
Network
History
1957: Founded the South Japan Dog Center (with an animal hospital) in Kagoshima City: Building images![]()
Started contracted safety testing (preclinical trials) as Japan’s first contracted pharmaceutical development research institution![]()
1960: Started contract work for safety testing (preclinical trials) as Japan's first contract research organization for pharmaceutical development![]()
Established a safety research institute in Yoshida Town, Kagoshima District (now Miyanoura Town, Kagoshima City) and relocated the headquarters![]()
1980: Established a safety research institute in Yoshida Town, Kagoshima District (now Miyanoura Town, Kagoshima City) and relocated the headquarters![]()
Successful construction of the world’s first online computer system in preparation for GLP (Good Laboratory Practice) "Standards for Conducting Nonclinical Safety Studies of Pharmaceuticals"![]()
1982: Prepared for the implementation of GLP (Good Laboratory Practice) "Standards for the conduct of nonclinical trials on drug safety" by successfully building the world's first online computer system![]()
Obtained GLP compliance from the Ministry of Health, Labour and Welfare and began safety testing; expanded the research building![]()
Obtained GLP compliance (first in Japan as a CRO) from the Ministry of Health, Labour and Welfare, started safety testing, and expanded the research building![]()
1983: Obtained GLP compliance (first in Japan as a CRO) from the Ministry of Health, Labour and Welfare, started safety testing, and expanded the research wing![]()
Divested the U.S. branch as SNBL U.S.A., Ltd. and built a clinical pharmacology testing medical institution (CPC Clinic) in Kagoshima City![]()
Divided U.S. branch into SNBL U.S.A., Ltd. and built a clinical pharmacology testing facility (CPC Clinic) in Kagoshima City![]()
1991: Divested the U.S. branch as SNBL U.S.A., Ltd.; built a clinical pharmacology testing medical facility (CPC Clinic) in Kagoshima City![]()
Established a drug metabolism analysis center in Kainan City, Wakayama Prefecture, and began analysis and pharmacokinetic testing services![]()
1998: Established a drug metabolism analysis center in Kainan City, Wakayama Prefecture; started analysis and pharmacokinetic testing services![]()
Started contracted Phase II and Phase III clinical trials, relocated SNBL U.S.A., Ltd. to Everett, a suburb of Seattle, and established a nonclinical testing facility![]()
Started contract clinical Phase II and III trials, relocated SNBL U.S.A., Ltd. to Everett, Washington, and established a new nonclinical testing facility![]()
1999: Started contract work for Phase II and Phase III clinical trials: Moved SNBL U.S.A., Ltd. to Everett, a suburb of Seattle, and established a nonclinical testing facility: Building images![]()
Listed on the Tokyo Stock Exchange Mothers market and built a clinical pharmacology testing medical institution on the campus of the University of Maryland in Baltimore, USA![]()
Listed on Tokyo Mothers Market and built a clinical pharmacology testing facility on the campus of the University of Maryland in Baltimore![]()
2004: Listed on the Tokyo Stock Exchange Mothers market; built a clinical pharmacology testing medical facility on the campus of the University of Maryland in Baltimore, USA![]()
Wave Life Sciences, a nucleic acid pharmaceutical developer, goes public on NASDAQ and establishes joint venture New Japan Science PPD Co., Ltd.![]()
Wave Life Sciences, a nucleic acid pharmaceutical developer (established 2012), goes public on NASDAQ and establishes joint venture New Japan Science PPD Co., Ltd.![]()
2015: Wave Life Sciences, a nucleic acid pharmaceutical developer (established by us in 2012), listed on the U.S. NASDAQ market: Established joint venture New Japan Science PPD Co., Ltd.![]()
Transition to Prime Market of new market segment on Tokyo Stock Exchange and consolidation of Inari Research Co., Ltd. as a subsidiary![]()
Transition to the Prime Market of the New Market Division at the Tokyo Stock Exchange, consolidating Inar Research Co., Ltd. as a subsidiary![]()
News
Kagoshima Science and Technology Consortium Partnership Agreement Ceremony
On July 21, 2026, a ceremony to conclude the KSTC partnership agreement was held at Kagoshima Prefectural Office. Kagoshima's universities, high schools, companies, and the Prefectural Board of Education collaborated to enhance inquiry activities and science and mathematics education. Shinnihon Science also expressed its intention to contribute to the development of future science talents in the region.